Loading people...
Arne Scheu is a life sciences researcher and technology analyst whose current professional role and primary location are not publicly disclosed. He earned a DPhil in biochemistry from the University of Oxford, where he studied as a highly competitive Rhodes Scholar selected from Germany. Prior to his doctoral studies, Scheu completed his academic training in molecular biotechnology at Heidelberg University. His scientific expertise centers on synthetic biology and protein engineering, specifically involving SpyTag and SpyCatcher technology developed during his time researching within the Howarth Lab. Beyond his laboratory work and co-authoring multiple peer-reviewed publications, he applies his scientific methodology to investment analysis, focusing on people research within the startup and venture capital sectors. Scheu currently focuses on bridging the gap between complex molecular biotechnology and strategic venture analysis in the broader technology ecosystem.
Arne Scheu is Founder at Valink Therapeutics.
Arne Scheu co-founded Valink Therapeutics.